Overview of acutely decompensated congestive heart failure (ADHF): A report from the ADHERE Registry

被引:124
作者
Fonarow, GC [1 ]
机构
[1] Univ Calif Los Angeles, Div Cardiol, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90095 USA
关键词
acute decompensated heart failure; hospitalization; registry; mortality; quality of care;
D O I
10.1007/s10741-005-6127-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute decompensated heart failure (ADHF) has emerged as a major public health problem, and HF has become the leading cause of hospitalization in persons over 65 years of age. It is estimated that there are 6.5 million hospital days attributed to ADHF each year. Patients hospitalized with ADHF face a substantial risk of readmission, as high as 50% by 6 months after discharge. Despite the large number of patients hospitalized and this substantial risk, data on these patients have been limited and there has been little effort to improve the quality of care for patients hospitalized with ADHF. The Acute Decompensated Heart Failure National Registry (ADHERE(R)) was designed to bridge this gap in knowledge and care by prospectively studying the characteristics, management, and outcomes of a broad spectrum of patients hospitalized with ADHF. Participating community and university hospitals identified patients with a primary or secondary discharge diagnosis of HF and collected medical history, management, treatments, and health outcomes via secure Web browser technology. As of October 2004, more than 160,000 patients from 281 hospitals have been enrolled. These patients differ substantially from those typically enrolled in randomized clinical trials. Initial data from the ADHERE registry have provided important insights into the clinical characteristics, patterns of care, and outcomes of patients with ADHF. ADHERE has documented significant delays in diagnosis and initiation of ADHF therapies as well as a substantial under-use of evidenced-based, guideline-recommended chronic HF therapies at hospital discharge. As such, there are substantial opportunities to improve the quality of care for ADHF patients in the nations hospitals.
引用
收藏
页码:179 / 185
页数:7
相关论文
共 12 条
[1]  
ABRAHAM WT, 2003, J CARD FAIL S1, V9, pS81
[2]  
ADAMS KF, 2000, J CARD FAIL, V6, P2
[3]  
*ADHERE, 3 QUART 2003 NAT BEN
[4]  
[Anonymous], 2004, HEART DIS STROK STAT
[5]   Short-term intravenous milrinone for acute exacerbation of chronic heart failure - A randomized controlled trial [J].
Cuffe, MS ;
Califf, RM ;
Adams, KF ;
Benza, R ;
Bourge, R ;
Colucci, WS ;
Massie, BM ;
O'Connor, CM ;
Pina, I ;
Quigg, R ;
Silver, MA ;
Georghiade, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (12) :1541-1547
[6]  
EMERMAN CL, 2002, ANN EMERG MED, V40, pS46
[7]   Improved treatment of coronary heart disease by implementation at a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) [J].
Fonarow, GC ;
Gawlinski, A ;
Moughrabi, S ;
Tillisch, IH .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (07) :819-822
[8]  
FONAROW GC, 2002, J CARD FAIL, V8, pS49
[9]  
Fonarow Gregg C, 2002, Rev Cardiovasc Med, V3 Suppl 3, pS2
[10]   Rationale, design, and methods for a Coreg (Carvedilol) heart failure registry (COHERE) [J].
Franciosa, JA ;
Abraham, WT ;
Fowler, M ;
Gilbert, EM ;
Greenberg, B ;
Massie, BM ;
Chen, T ;
Lukas, MA ;
Nelson, JJ .
JOURNAL OF CARDIAC FAILURE, 2000, 6 (03) :264-271